Cancer News and Research

Latest Cancer News and Research

Precise immune disturbances leading to Coeliac disease: More insight

New research has identified four aspects of immune system disturbance which lead to the development of coeliac disease. Nearly 40 different inherited risk factors which predispose to the disease have now been identified. These latest findings could speed the way towards improved diagnostics and treatments for the autoimmune complaint that affects 1 in 100 of the population, and lead to insights into related conditions such as type 1 diabetes.

28 Feb 2010

Brain cancer awareness: 55-year-old cycles across USA

Anne Feeley, a 55-year-old mother and brain cancer survivor, will cycle across the country this spring to raise awareness and money for brain cancer research and support.

27 Feb 2010

Unexplained, sudden anemia: Brown recluse spider bite

As spring approaches and people return to outdoor activities, caution should be taken in areas of the country that are home to Loxosceles reclusa, also called the brown recluse spider. A new study from St. Jude Children's Research Hospital found that when patients present with sudden anemia, but the cause is elusive, the brown recluse spider should be part of the differential diagnosis, at least in parts of the nation where the spider is regularly found.

27 Feb 2010

Kidney Cancer Canada: Survival, support, understanding, research and hope

Survival. Support. Understanding. Research. Hope. These are five words that mean a great deal to Kidney Cancer Canada as National Kidney Month kicks off this March.

27 Feb 2010

Body repairs itself through microvesicles: New hope for tissue regeneration

Researchers at Rhode Island Hospital have discovered how cells communicate with each other during times of cellular injury. The findings shed new light on how the body repairs itself when organs become diseased, through small particles known as microvesicles, and offers hope for tissue regeneration.

27 Feb 2010

MDB Capital Group selects Health Discovery as one of Top 50 “Best and Brightest” companies

Health Discovery Corporation announced today it has been selected by MDB Capital Group as one of its Top 50 “Best and Brightest” companies that will present at the invitation-only, 1st Annual Bright Lights Conference, the first public company conference to focus exclusively on companies with disruptive and market changing intellectual property.

27 Feb 2010

Electronic prescribing decreases prescription errors

Should doctors around the country use e-prescribing to decrease prescription errors? A study led by physician-scientists from Weill Cornell Medical College found that health care providers using an electronic system to write prescriptions were seven times less likely to make errors than those writing their prescriptions by hand. The study appears today in the online edition of the Journal of General Internal Medicine.

27 Feb 2010

Ensure radiation therapy from certified technologists with ongoing qualifications

Every day in the United States, tens of thousands of patients are exposed to ionizing radiation through radiation therapy, CT scans, x rays, mammograms, and other medical imaging and therapeutic procedures. Patients need to have confidence that the technologists caring for them have the credentials and qualifications to safely administer radiation, and that the equipment they are using is properly calibrated and maintained to deliver radiation safely and within the proper dose parameters.

27 Feb 2010

Researchers develop noninvasive infrared scanning system to diagnose melanomas

Johns Hopkins researchers have developed a noninvasive infrared scanning system to help doctors determine whether pigmented skin growths are benign moles or melanoma, a lethal form of cancer.

27 Feb 2010

Fear of increased tobacco industry influence over policymakers due to business-friendly 'Better Regulation' reforms

Experts have urged the European Commission to ensure it focuses on public health when developing policies, rather than succumbing to pressure from the tobacco industry.

27 Feb 2010

Thomas Jefferson University Hospital CLP receives Outstanding Performance Award

Adam Berger, M.D., a Cancer Liaison Physician (CLP) at Thomas Jefferson University Hospital, recently received an Outstanding Performance Award for going above and beyond the scope of the normal duties of serving as a liaison between the hospital's cancer program and the American College of Surgeons Commission on Cancer (CoC).

27 Feb 2010

UAMS researchers identify age-related mechanism as primary cause of osteoporosis

Marking a shift in decades of thought on the cause of osteoporosis, researchers at the University of Arkansas for Medical Sciences have identified an age-related mechanism - not a decrease of the hormone estrogen - as the primary culprit.

27 Feb 2010

For people who carry common gene variants, smoking increases risk of aneurysm

For people who carry common gene variants, cigarette smoking greatly increases the risk that a blood vessel in the brain will weaken and balloon out - called an aneurysm - which could be life-threatening if it ruptures, according to research presented at the American Stroke Association's International Stroke Conference 2010.

27 Feb 2010

MLL cancer cells rely on normal protein to proliferate

Researchers have found that one particularly aggressive type of blood cancer, mixed lineage leukemia (MLL), has an unusual way to keep the molecular motors running. The cancer cells rely on the normal version of an associated protein to stay alive.

27 Feb 2010

iBioLaunch platform technology to be licensed for plant-expressed influenza vaccines project

iBio, Inc. announced today that it has agreed in principle to license its technology, the iBioLaunch™ platform, and provide technology transfer services to G-Con, LLC, a private Texas company, and its affiliates, for the development and manufacture of plant-expressed influenza vaccines at a new facility being constructed in Bryan, Texas. The “GreenVax Project” will show proof of concept for a large-scale vaccine production facility using Nicotiana plants grown hydroponically in a contained environment.

27 Feb 2010

MedQuist integrates DEP with new features of Epic Systems' Hyperspace Client

MedQuist Inc., a leading provider of technology-enabled clinical documentation services, is integrating with Epic Systems Corporation within its Hyperspace environment to offer a solution that integrates "partial dictations" with the template-based clinical documentation process, enabling physicians to complete the Electronic Health Record (EHR) without changing their documentation workflow.

27 Feb 2010

Cell Therapeutics files 2009 Annual Report on Form 10-K

Cell Therapeutics, Inc. today announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2009. This filing is available for review on CTI's website at www.CellTherapeutics.com, or on the Securities and Exchange Commission's website at www.sec.gov.

27 Feb 2010

CHI lauds California state Assembly's proclamation of Feb. 28, as Rare Disease Day

CHI-California Healthcare Institute, a non-profit public policy research organization, applauds the state Assembly’s proclamation of Feb. 28, as Rare Disease Day. This day helps bring awareness of the biomedical companies that are dedicated to researching and developing treatments for patients suffering from rare diseases.

27 Feb 2010

Synta Pharmaceuticals presents preclinical and clinical data of Hsp90 inhibitor STA-9090

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Dr. Geoffrey I. Shapiro of Dana-Farber Cancer Institute, presented preclinical and clinical data on STA-9090, a potent second-generation Hsp90 inhibitor, at IASLC (International Association for the Study of Lung Cancer) 10th Annual Targeted Therapies of the Treatment of Lung Cancer Meeting in Santa Monica, CA.

27 Feb 2010

NIH awards $3M grant to VCU Massey Cancer Center to develop test to measure health literacy of cancer patients

The National Institutes of Health has awarded the Virginia Commonwealth Massey Cancer Center a National Cancer Institute grant totaling nearly $3 million to develop a standardized test to measure health literacy among cancer patients.

27 Feb 2010

Cancer News and Research

Latest Cancer News and Research

Precise immune disturbances leading to Coeliac disease: More insight

Brain cancer awareness: 55-year-old cycles across USA

Unexplained, sudden anemia: Brown recluse spider bite

Kidney Cancer Canada: Survival, support, understanding, research and hope

Body repairs itself through microvesicles: New hope for tissue regeneration

MDB Capital Group selects Health Discovery as one of Top 50 “Best and Brightest” companies

Electronic prescribing decreases prescription errors

Ensure radiation therapy from certified technologists with ongoing qualifications

Researchers develop noninvasive infrared scanning system to diagnose melanomas

Fear of increased tobacco industry influence over policymakers due to business-friendly 'Better Regulation' reforms

Thomas Jefferson University Hospital CLP receives Outstanding Performance Award

UAMS researchers identify age-related mechanism as primary cause of osteoporosis

For people who carry common gene variants, smoking increases risk of aneurysm

MLL cancer cells rely on normal protein to proliferate

iBioLaunch platform technology to be licensed for plant-expressed influenza vaccines project

MedQuist integrates DEP with new features of Epic Systems' Hyperspace Client

Cell Therapeutics files 2009 Annual Report on Form 10-K

CHI lauds California state Assembly's proclamation of Feb. 28, as Rare Disease Day

Synta Pharmaceuticals presents preclinical and clinical data of Hsp90 inhibitor STA-9090

NIH awards $3M grant to VCU Massey Cancer Center to develop test to measure health literacy of cancer patients

Industry Focus: Cell & Gene Therapy eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Cancer News and Research

Latest Cancer News and Research

Industry Focus: Cell & Gene Therapy eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in